Authors acknowledge that both the 2022 World Health Organization and International Consensus Classification myelodysplastic syndrome criteria sets have value, while sorting out their similarities and ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
BACKGROUND. Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AML). Given ...
NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and identifying patients most likely t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results